Dr. Muhammad Zeeshan Danish has completed his PhD from the top most School of Pharmacy, University of Nottingham U.K. His work was completed with International patent based DNA and RNA Gene technology for Medical and Environmental Applications. This technology was transferred to TraceTag international, where he worked as a technology transfer Associate and trained their scientists as a Postdoctoral candidate in Wales (Cardiff) U.K. He is HEC approved PhD supervisor and also the Author of two patents and more than 25 impact factor peer reviewed publications and more than 50 abstracts published in national and international proceedings and conferences. He is also the distinguished Editor of International Journal of RNAi and Gene Silencing and Chief Editor of the Journal of United Medical and Pharmaceutical Sciences (JUMPS). He has the honour to be the member of the panel of expert on biologicals for Drug Regulatory Authority Pakistan (DRAP). Dr. Zeeshan is serving at Punjab University College of Pharmacy since 2004 and has also the International teaching experience at School of Pharmacy, University of Nottingham U.K for three years. He is supervising PhD and M.Phil research students in Germany, France, Malaysia and various Local Universities. He has also been selected as a Visiting Research fellow at City of Orlando, Ventura, Florida, and U.S.A in 2015 to develop a model of biotechnological product development for clinical trial settings. His area of research includes Nanotechnology, Advanced Drug delivery, Gene Silencing/Gene Expression, Drug Discovery, Aptamer therapeutics, Antibodies, Cancer therapeutics, Vaccines, Molecular Biomarkers, phytochemical analysis, product development and designing Pharmaceutical/public health strategies. He is the member of International society of Aptamers and RNAi and Gene silencing, Royal society of Chemicals and United Kingdome and Ireland controlled release society and Pakistan.